COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • August 9th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 9th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured promissory note in the principal amount of $2,750,000.00 to the Holder (as defined below) of even date) (the “Note”), CFIC-2015 NV FAMILY INVESTMENTS, LLC (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 2,750,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated August 7, 2024, by and among the Company and the Holder (the
COMMON STOCK PURCHASE WARRANT ICORECONNECT INC.Security Agreement • August 1st, 2024 • iCoreConnect Inc. • Services-prepackaged software
Contract Type FiledAugust 1st, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ], a [ ] (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from ICORECONNECT INC., a Delaware corporation (the “Company”), [ ] shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is being issued to the Holder pursuant to that certain waiver entered into between the Company and Holder on the Issuance Date (the “Waiver”).
COMMON STOCK PURCHASE WARRANT LA ROSA HOLDINGS CORP.Security Agreement • July 19th, 2024 • La Rosa Holdings Corp. • Real estate agents & managers (for others)
Contract Type FiledJuly 19th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $468,000.00 to the Holder (as defined below) of even date) (the “Note”), [*] (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from LA ROSA HOLDINGS CORP., a Nevada corporation (the “Company”), 53,700 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated July 16, 2024, by and among the Company and the Holder (the “Purchase Agreement”).
COMMON STOCK PURCHASE WARRANT LA ROSA HOLDINGS CORP.Security Agreement • July 19th, 2024 • La Rosa Holdings Corp. • Real estate agents & managers (for others)
Contract Type FiledJuly 19th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $468,000.00 to the Holder (as defined below) of even date) (the “Note”), [*] (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from LA ROSA HOLDINGS CORP., a Nevada corporation (the “Company”), 54,200 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated July 16, 2024, by and among the Company and the Holder (the “Purchase Agreement”).
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • June 21st, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJune 21st, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured zero coupon promissory note in the principal amount of $330,000.00 to the Holder (as defined below) of even date) (the “Note”), AJB CAPITAL INVESTMENTS LLC (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 330,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated May 9, 2024, by and among the Company and the Holder (the “Pu
COMMON STOCK PURCHASE WARRANT SIGNING DAY SPORTS, INC.Security Agreement • June 20th, 2024 • Signing Day Sports, Inc. • Services-computer processing & data preparation
Contract Type FiledJune 20th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $198,611.00 to the Holder (as defined below) of even date) (the “Note”), FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from SIGNING DAY SPORTS, INC., a Delaware corporation (the “Company”), 662,036 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated June 18, 202
COMMON STOCK PURCHASE WARRANT SIGNING DAY SPORTS, INC.Security Agreement • June 20th, 2024 • Signing Day Sports, Inc. • Services-computer processing & data preparation
Contract Type FiledJune 20th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $198,611.00 to the Holder (as defined below) of even date) (the “Note”), FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from SIGNING DAY SPORTS, INC., a Delaware corporation (the “Company”), 120,370 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated June 18, 202
COMMON STOCK PURCHASE WARRANT LYTUS TECHNOLOGIES HOLDINGS PTV. LTD.Security Agreement • June 14th, 2024 • Lytus Technologies Holdings PTV. Ltd. • Services-computer processing & data preparation
Contract Type FiledJune 14th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $_____________ to the Holder (as defined below) of even date) (the “Note”), [HOLDER], _________________ (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from LYTUS TECHNOLOGIES HOLDINGS PTV. LTD., a British Virgin Islands company (the “Company”), ____________ shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated June 3, 2024, by and among the C
COMMON STOCK PURCHASE WARRANT LYTUS TECHNOLOGIES HOLDINGS PTV. LTD.Security Agreement • June 14th, 2024 • Lytus Technologies Holdings PTV. Ltd. • Services-computer processing & data preparation
Contract Type FiledJune 14th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the execution of the Purchase Agreement (as defined below), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from LYTUS TECHNOLOGIES HOLDINGS PTV. LTD., a British Virgin Islands company (the “Company”), 51,195 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain equity purchase agreement dated June 3, 2024, by and among the Company and the Holder (the “Purchase Agreement”).
COMMON STOCK PURCHASE WARRANT AVALON GLOBOCARE CORP.Security Agreement • June 5th, 2024 • Avalon GloboCare Corp. • Biological products, (no disgnostic substances)
Contract Type FiledJune 5th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $2,845,000.00 to the Holder (as defined below) of even date) (the “Note”), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from AVALON GLOBOCARE CORP., a Delaware corporation (the “Company”), 1,200,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated June 5, 2024, by and among the Compa
COMMON STOCK PURCHASE WARRANT AVALON GLOBOCARE CORP.Security Agreement • June 5th, 2024 • Avalon GloboCare Corp. • Biological products, (no disgnostic substances)
Contract Type FiledJune 5th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $2,845,000.00 to the Holder (as defined below) of even date) (the “Note”), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from AVALON GLOBOCARE CORP., a Delaware corporation (the “Company”), 1,000,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated June 5, 2024, by and among the Compa
COMMON STOCK PURCHASE WARRANT AVALON GLOBOCARE CORP.Security Agreement • May 31st, 2024 • Avalon GloboCare Corp. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 31st, 2024 Company Industry JurisdictionThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $700,000.00 to the Holder (as defined below) of even date) (the “Note”), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from AVALON GLOBOCARE CORP., a Delaware corporation (the “Company”), 131,250 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated March 7, 2024, by and among the Company
COMMON STOCK PURCHASE WARRANT SIGNING DAY SPORTS, INC.Security Agreement • May 17th, 2024 • Signing Day Sports, Inc. • Services-computer processing & data preparation
Contract Type FiledMay 17th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $412,500.00 to the Holder (as defined below) of even date) (the “Note”), FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from SIGNING DAY SPORTS, INC., a Delaware corporation (the “Company”), 1,375,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated May 16, 20
COMMON STOCK PURCHASE WARRANT SIGNING DAY SPORTS, INC.Security Agreement • May 17th, 2024 • Signing Day Sports, Inc. • Services-computer processing & data preparation
Contract Type FiledMay 17th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $412,500.00 to the Holder (as defined below) of even date) (the “Note”), FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from SIGNING DAY SPORTS, INC., a Delaware corporation (the “Company”), 250,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated May 16, 2024
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • May 10th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMay 10th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured promissory note in the principal amount of $220,000.00 to the Holder (as defined below) of even date) (the “Note”), Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Capital, LLC (including any permitted and registered assigns, collectively, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 220,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • May 10th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMay 10th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured promissory note in the principal amount of $330,000.00 to the Holder (as defined below) of even date) (the “Note”), AJB CAPITAL INVESTMENTS LLC (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 330,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated May 9, 2024, by and among the Company and the Holder (the “Purchase Agree
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • May 10th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Nevis
Contract Type FiledMay 10th, 2024 Company Industry JurisdictionThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured zero coupon promissory note in the principal amount of $616,000.00 to the Holder (as defined below) of even date) (the “Note”), GENERATING ALPHA LTD (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 550,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated May 7, 2024, by and among the Company and the Holder (the “Purchase
COMMON STOCK PURCHASE WARRANT HEMPACCO CO., INC.Security Agreement • April 30th, 2024 • Hempacco Co., Inc. • Cigarettes
Contract Type FiledApril 30th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $379,288.88 to the Holder (as defined below) of even date) (the “Note”), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from HEMPACCO CO., INC., a Nevada corporation (the “Company”), 113,786 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated April 23, 2024, by and among the Company and the Holder (the
COMMON STOCK PURCHASE WARRANT LA ROSA HOLDINGS CORP.Security Agreement • April 16th, 2024 • La Rosa Holdings Corp. • Real estate agents & managers (for others) • Nevada
Contract Type FiledApril 16th, 2024 Company Industry JurisdictionThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Alexander Capital L.P. (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from LA ROSA HOLDINGS CORP., a Nevada corporation (the “Company”), 21,053 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and Alexander Capital L.P., dated as of January 12, 2024.
COMMON STOCK PURCHASE WARRANT INVO BIOSCIENCE, INC.Security Agreement • April 11th, 2024 • INVO Bioscience, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledApril 11th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $275,000.00 to the Holder (as defined below) of even date) (the “Note”), FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from INVO BIOSCIENCE, INC., a Nevada corporation (the “Company”), 229,167 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated April 5, 2024, by and among the
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • April 11th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 11th, 2024 Company Industry JurisdictionThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the loan of up to $5,000,000 made upon the entry into of the Equity and Business Loan Agreement dated as of the date hereof among NKGEN OPERATING BIOTECH, INC., NKGEN BIOTECH, INC. (the “Company”), and BDW INVESTMENTS LLC (including any permitted and registered assigns, the “Holder”), (the “Agreement”)), the Holder is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from the Company), 1,000,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect.
COMMON STOCK PURCHASE WARRANT INVO BIOSCIENCE, INC.Security Agreement • April 11th, 2024 • INVO Bioscience, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledApril 11th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $275,000.00 to the Holder (as defined below) of even date) (the “Note”), FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from INVO BIOSCIENCE, INC., a Nevada corporation (the “Company”), 500,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated April 5, 2024, by and among the
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • April 5th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 5th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured promissory note in the principal amount of $330,000.00 to the Holder (as defined below) of even date) (the “Note”), AJB CAPITAL INVESTMENTS LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 330,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated April 1, 2024, by and among the Com
COMMON STOCK PURCHASE WARRANT LA ROSA HOLDINGS CORP.Security Agreement • April 5th, 2024 • La Rosa Holdings Corp. • Real estate agents & managers (for others)
Contract Type FiledApril 5th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $1,316,000.00 to the Holder (as defined below) of even date) (the “Note”), [*], a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from LA ROSA HOLDINGS CORP., a Nevada corporation (the “Company”), 150,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated April 1, 2024, by and among the Company and the Holder (t
COMMON STOCK PURCHASE WARRANT CLEARDAY, INC.Security Agreement • April 5th, 2024 • Clearday, Inc. • Services-nursing & personal care facilities
Contract Type FiledApril 5th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $1,558,000.00 to the Holder (as defined below) of even date) (the “Note”), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from CLEARDAY, INC., a Delaware corporation (the “Company”), 405,298 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated , 2024, by and among the Company and the Holder (the “Purchas
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • April 5th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 5th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured promissory note in the principal amount of $220,000.00 to the Holder (as defined below) of even date) (the “Note”), Sandia Investment Management LP on behalf of Diametric True Alpha Market Neutral Master Fund LP and Diametric True Alpha Enhanced Market Neutral Master Fund LP (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 220,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connec
COMMON STOCK PURCHASE WARRANT CLEARDAY, INC.Security Agreement • April 5th, 2024 • Clearday, Inc. • Services-nursing & personal care facilities
Contract Type FiledApril 5th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $1,558,000.00 to the Holder (as defined below) of even date) (the “Note”), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from CLEARDAY, INC., a Delaware corporation (the “Company”), 1,688,741 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated , 2024, by and among the Company and the Holder (the “Purch
COMMON STOCK PURCHASE WARRANT LA ROSA HOLDINGS CORP.Security Agreement • April 5th, 2024 • La Rosa Holdings Corp. • Real estate agents & managers (for others)
Contract Type FiledApril 5th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $1,316,000.00 to the Holder (as defined below) of even date) (the “Note”), [*], a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from LA ROSA HOLDINGS CORP., a Nevada corporation (the “Company”), 152,300 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated April 1, 2024, by and among the Company and the Holder (t
COMMON STOCK PURCHASE WARRANT HEMPACCO CO., INC.Security Agreement • April 2nd, 2024 • Hempacco Co., Inc. • Cigarettes
Contract Type FiledApril 2nd, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $111,111.11 to the Holder (as defined below) of even date) (the “Note”), FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from HEMPACCO CO., INC., a Nevada corporation (the “Company”), 33,333 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated March 29, 2024, by and among the Com
COMMON STOCK PURCHASE WARRANT HEMPACCO CO., INC.Security Agreement • March 28th, 2024 • Hempacco Co., Inc. • Cigarettes
Contract Type FiledMarch 28th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $379,288.88 to the Holder (as defined below) of even date) (the “Note”), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from HEMPACCO CO., INC., a Nevada corporation (the “Company”), 113,786 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated March 25, 2024, by and among the Company and the Holder (the
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • March 27th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 27th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured promissory note in the principal amount of $330,000.00 to the Holder (as defined below) of even date) (the “Note”), Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Capital, LLC (including any permitted and registered assigns, the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 330,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agree
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • March 27th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 27th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured promissory note in the principal amount of $330,000.00 to the Holder (as defined below) of even date) (the “Note”), FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 330,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated March 21, 2024, by and
COMMON STOCK PURCHASE WARRANT LA ROSA HOLDINGS CORP.Security Agreement • February 26th, 2024 • La Rosa Holdings Corp. • Real estate agents & managers (for others)
Contract Type FiledFebruary 26th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $1,052,631.58 to the Holder (as defined below) of even date) (the “Note”), [______] (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from LA ROSA HOLDINGS CORP., a Nevada corporation (the “Company”), 120,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated February 20, 2024, by and among the Company and the Holder (the “Purchase Agreement”
COMMON STOCK PURCHASE WARRANT LA ROSA HOLDINGS CORP.Security Agreement • February 26th, 2024 • La Rosa Holdings Corp. • Real estate agents & managers (for others)
Contract Type FiledFebruary 26th, 2024 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the senior secured promissory note in the principal amount of $1,052,631.58 to the Holder (as defined below) of even date) (the “Note”), [______] (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from LA ROSA HOLDINGS CORP., a Nevada corporation (the “Company”), 95,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated February 20, 2024, by and among the Company and the Holder (the “Purchase Agreement”)
COMMON STOCK PURCHASE WARRANT HEMPACCO CO., INC.Security Agreement • January 12th, 2024 • Hempacco Co., Inc. • Cigarettes • Delaware
Contract Type FiledJanuary 12th, 2024 Company Industry JurisdictionThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $774,444.44 to the Holder (as defined below) of even date) (the “Note”), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from HEMPACCO CO., INC., a Nevada corporation (the “Company”), 335,591 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated January 8, 2024, by and among the Company and the Holder (the